Literature DB >> 24885450

Diverse attention deficits in patients with neurologically symptomatic and asymptomatic Wilson's disease.

Szczepan Iwański1, Joanna Seniów1, Marcin Leśniak1, Tomasz Litwin1, Anna Członkowska2.   

Abstract

OBJECTIVE: Cognitive deficits in patients with Wilson's disease (WD) have been reported in several studies, but there was no detailed analysis of the various components of attention, one of the most significant factors of the executive system. Our study determined the pattern of deficits in attention subsystems in WD patients, including selective attention, divided attention, attention switching, and sustained attention.
METHOD: We examined 67 WD patients using the Test of Everyday Attention (TEA)-33 participants with neurological symptoms and 34 who were neurologically asymptomatic, but most with mild hepatic dysfunctions. The results were compared with 43 matched healthy controls.
RESULTS: The group of WD patients with neurological symptoms performed significantly worse (p < .05) in all components of attention: sustained attention, selective attention, divided attention, and attentional switching. WD patients without neurological symptoms exhibited significantly lower results in one component-sustained attention (p < .05). None of the TEA subtests scores were associated significantly with Unified Wilson's Disease Rating Scale scores, which may reflect that the cognitive and neurological consequences of WD are relatively independent.
CONCLUSIONS: We found a deficiency in all components of attention in neurological WD patients. The most frequently disturbed function was attention switching. Relatively milder deficits concerned divided, selective, and sustained attention. These are all abilities creating the core of the executive system and are regulated by subcortical prefrontal circuits, which are usually dysfunctional in WD patients. In neurologically asymptomatic patients, an isolated deficit of sustained attention occurs; this may be a sign of mild hepatic encephalopathy. PsycINFO Database Record (c) 2015 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24885450     DOI: 10.1037/neu0000103

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  8 in total

Review 1.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

Review 2.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

Review 3.  Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Authors:  Jan Aaseth; Jan Alexander; Geir Bjørklund; Knut Hestad; Petr Dusek; Per M Roos; Urban Alehagen
Journal:  Biometals       Date:  2016-08-16       Impact factor: 2.949

4.  Comparative assessment of clinical rating scales in Wilson's disease.

Authors:  Hanna M Volpert; Jan Pfeiffenberger; Jan B Gröner; Wolfgang Stremmel; Daniel N Gotthardt; Mark Schäfer; Karl Heinz Weiss; Markus Weiler
Journal:  BMC Neurol       Date:  2017-07-21       Impact factor: 2.474

5.  Social cognition in Wilson's disease: A new phenotype?

Authors:  Elodie Peyroux; Nelly Santaella; Emmanuel Broussolle; Caroline Rigard; Emilie Favre; Anne-Sophie Brunet; Muriel Bost; Alain Lachaux; Caroline Demily
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 6.  Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Authors:  Tomasz Litwin; Petr Dusek; Tomasz Szafrański; Karolina Dzieżyc; Anna Członkowska; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-06

7.  Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.

Authors:  Liang-Yong Li; Wen-Ming Yang; Huai-Zhen Chen; Yun-Hu Wu; Xiang Fang; Jing Zhang; Zhen Wang; Yong-Sheng Han; Yu Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson's disease.

Authors:  Marcin Leśniak; Magdalena Roessler-Górecka; Anna Członkowska; Joanna Seniów
Journal:  Neurol Sci       Date:  2021-06-14       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.